Capital Advisory Group Advisory Services, LLC Caribou Biosciences, Inc. Transaction History
Capital Advisory Group Advisory Services, LLC
- $274 Million
- Q2 2025
A detailed history of Capital Advisory Group Advisory Services, LLC transactions in Caribou Biosciences, Inc. stock. As of the latest transaction made, Capital Advisory Group Advisory Services, LLC holds 11,500 shares of CRBU stock, worth $17,825. This represents 0.01% of its overall portfolio holdings.
Number of Shares
11,500Holding current value
$17,825% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding CRBU
# of Institutions
137Shares Held
47MCall Options Held
17.1KPut Options Held
58.1K-
Black Rock Inc. New York, NY6.95MShares$10.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.52MShares$7.01 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ3.27MShares$5.07 Million0.25% of portfolio
-
Pfm Health Sciences, LP San Francisco, CA2.51MShares$3.88 Million0.18% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY2.35MShares$3.64 Million0.01% of portfolio
About Caribou Biosciences, Inc.
- Ticker CRBU
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,840,800
- Market Cap $94.3M
- Description
- Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...